The research of "blood activating and stasis-removing"in traditional Chinese medicine and antiplatelet drug for treatment of coronary heart disease
LüShichao
ZHANG Junping
Abstract：Coronary heart disease is one of the common clinical cardiovascular disease , its rate of prevalence is rising.Antiplatelet therapy is the most important treatment of coronary heart di -sease, which can effectively reduce the incidence of cardiovascular events .Although percutaneous coronary intervention(PCI) open up a new situation in the treatment of coronary heart disease , anti-platelet therapy is essential before and after intervention .With the widespread using of antiplatelet drugs, the decline of resistant phenomenon and non -specific therapeutic response gradually attracted attention, but the combine of therapy lead to increases of bleeding and other side effects .Due to the effective efficacy and less side effects of "Blood Activating and Stasis-removing"traditional Chinese medicine (TCM) in the treatment of coronary heart disease, therefore, the majority of clinical coronary heart disease patients take one kind of "Blood Activating and Stasis-removing"TCM at least,someone even take multiple.However, it still need multiple samples, multi-center and randomized controlled trial study to evaluate the efficacy and safety of the "Blood activating and Stasis-removing"TCM and the antiplatelet drug in treatment of coronary heart disease .Further more, the mechanism of "blood activating and stasis-removing"TCM and the interactive relationship of it with antiplatelet drug in treating coronary heart disease should be definitude , which can provide reference to guide clinical rational and standard drug application .
Keywords：Coronary heart diseasePercutaneous coronary intervention (PCI)Traditional Chinese medicine (TCM)Antiplatelet
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 158-161,179 )